Increased expression of p21-activated kinase 4 in adenomyosis and its regulation of matrix metalloproteinase-2 and -9 in endometrial cells

Fertility and Sterility

Volumn 103, Issue 4, 2015, Pages 1089-1097.e2

  Yi, Kyong Wook ^a   Kim, Sung Hoon ^b   Ihm, Hyo Jin ^b   Oh, Young Sang ^b   Chae, Hee Dong ^b   Kim, Chung Hoon ^b   Kang, Byung Moon ^b  

^a Korea University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Adenomyosis; Endometrium; Matrix metalloproteinase (MMP); Nuclear factor kappa B (NF B); P21 activated kinase 4 (Pak4)

Indexed keywords

GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; P21 ACTIVATED KINASE 4; PYRROLIDINE DITHIOCARBAMATE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; P21 ACTIVATED KINASE; PAK4 PROTEIN, HUMAN;

ADENOMYOSIS; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOLIC FRACTION; DNA BINDING; ENDOMETRIOSIS; ENDOMETRIUM CELL; ENZYME REGULATION; EXPERIMENTAL STUDY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; UTERINE CERVIX CARCINOMA IN SITU; WESTERN BLOTTING; ZYMOGRAPHY; CELL CULTURE; CELL MOTION; DRUG EFFECTS; ENDOMETRIUM; ENZYME ACTIVATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; UPREGULATION;

ADENOMYOSIS; ADULT; CELL MOVEMENT; CELLS, CULTURED; ENDOMETRIUM; ENZYME ACTIVATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; P21-ACTIVATED KINASES; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84930809510     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.12.124     Document Type: Article

References (45)

1. Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod Update 1998;4: 312-22.
2. Curtis KM, Hillis SD, Marchbanks PA, Peterson HB. Disruption of the endometrial-myometrial border during pregnancy as a risk factor for adenomyosis. Am J Obstet Gynecol 2002;187:543-4.
3. Kumar R, Gururaj AE, Barnes CJ. p21-activated kinases in cancer. Nat Rev Cancer 2006;6:459-71.
4. Eswaran J, Soundararajan M, Kumar R, Knapp S. UnPAKing the class differences among p21-activated kinases. Trends BiochemSci 2008;33:394-403.
5. Jaffer ZM, Chernoff J. p21-activated kinases: Three more join the Pak. Int J Biochem Cell Biol 2002;34:713-7.
6. Dart AE, Wells CM. P21-activated kinase 4-not just one of the PAK. Eur J Cell Biol 2013;92:129-38.
7. Callow MG, Clairvoyant F, Zhu S, Schryver B, Whyte DB, Bischoff JR, et al. Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J Biol Chem 2002;277:550-8.
8. Liu Y, Chen N, Cui X, Zheng X, Deng L, Price S, et al. The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis. Oncogene 2010;29:5883-94.
9. Parsons DW, Wang TL, Samuels Y, Bardelli A, Cummins JM, DeLong L, et al. Colorectal cancer: mutations in a signalling pathway. Nature 2005;436: 792.
10. Siu MK, Chan HY, Kong DS, Wong ES, Wong OG, Ngan HY, et al. p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients. Proc Natl Acad Sci U S A 2010;107:18622-7.
11. Kesanakurti D, Chetty C, Rajasekhar Maddirela D, Gujrati M, Rao JS. Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma. Cell Death Dis 2012;3:e445.
12. Kim SH, Kim SR, Ihm HJ, Oh YS, Chae HD, Kim CH, et al. Regulation of P21-activated kinase-4 by progesterone and tumor necrosis factor-alpha in human endometrium and its increased expression in advanced-stage endometriosis. J Clin Endocrinol Metab 2014;98:E238-48.
13. Chen Q, Jin M, Yang F, Zhu J, Xiao Q, Zhang L. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm 2013;2013:928315.
14. Bachmeier BE, Rohrbach H, De Waal J, Jochum M, Nerlich AG. Enhanced expression and activation of major matrix metalloproteinases in distinct topographic areas of invasive breast carcinomas. Int J Oncol 2005;26: 1203-7.
15. Chung HW, Wen Y, Chun SH, Nezhat C, Woo BH, Lake Polan M. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: A rationale for endometriotic invasiveness. Fertil Steril 2001;75:152-9.
16. Tokyol C, Aktepe F, Dilek FH, Sahin O, Arioz DT. Expression of cyclooxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis. Int J Gynecol Pathol 2009;28:148-56.
17. Li T, Li YG, Pu DM. Matrix metalloproteinase-2 and-9 expression correlated with angiogenesis in human adenomyosis. Gynecol Obstet Invest 2006;62: 229-35.
18. Kim SH, Ihm HJ, Oh YS, Chae HD, Kim CH, Kang BM. Increased nuclear expression of nuclear factor kappa-B p65 subunit in the eutopic endometrium and ovarian endometrioma of women with advanced stage endometriosis. Am J Reprod Immunol 2013;70:497-508.
19. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol 1975;122:262-3.
20. Arici A, Head JR, MacDonald PC, Casey ML. Regulation of interleukin-8 gene expression in human endometrial cells in culture. Mol Cell Endocrinol 1993; 94:195-204.
21. Kim SH, Lee HW, Kim YH, Koo YH, Chae HD, Kim CH, et al. Down-regulation of p21-activated kinase 1 by progestin and its increased expression in the eutopic endometrium of women with endometriosis. Hum Reprod 2009; 24:1133-41.
22. Lee SR, Kim SH, Lee HW, Kim YH, Chae HD, Kim CH, et al. Increased expression of glutathione by estradiol, tumor necrosis factor-alpha, and interleukin 1-beta in endometrial stromal cells. Am J Reprod Immunol 2009;62:352-6.
23. Benagiano G, Habiba M, Brosens I. The pathophysiology of uterine adenomyosis: An update. Fertil Steril 2012;98:572-9.
24. Vercellini P, Vigano P, Somigliana E, Daguati R, Abbiati A, Fedele L. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynaecol 2006; 20:465-77.
25. Arnold LL, Meck JM, Simon JA. Adenomyosis: evidence for genetic cause. Am J Med Genet 1995;55:505-6.
26. Benagiano G, Brosens I, Habiba M. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis. Hum Reprod Update 2014;20:386-402.
27. Benagiano G, Brosens I. The endometrium in adenomyosis. Womens Health (Lond Engl) 2012;8:301-12.
28. Yang JH, Wu MY, Chen MJ, Chen SU, Yang YS, Ho HN. Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis. Fertil Steril 2009;91:2193-8.
29. Lu W, Xia YH, Qu JJ, He YY, Li BL, Lu C, et al. p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion. Neoplasma 2013;60:493-503.
30. Gonzalez-Ramos R, Donnez J, Defrere S, Leclercq I, Squifflet J, Lousse JC, et al. Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis. Mol Hum Reprod 2007;13:503-9.
31. Gonzalez-Ramos R, Van Langendonckt A, Defrere S, Lousse JC, Colette S, Devoto L, et al. Involvement of the nuclear factor-kB pathway in the pathogenesis of endometriosis. Fertil Steril 2010;94:1985-94.
32. Guo SW. Nuclear factor-kappab (NF-kappaB): An unsuspected major culprit in the pathogenesis of endometriosis that is still at large? Gynecol Obstet Invest 2007;63:71-97.
33. Li B, Chen M, Liu X, Guo SW. Constitutive and tumor necrosis factor-alphainduced activation of nuclear factor-kappaB in adenomyosis and its inhibition by andrographolide. Fertil Steril 2013;100:568-77.
34. Nie J, Lu Y, Liu X, Guo SW. Immunoreactivity of progesterone receptor isoform B, nuclear factor kappaB, and IkappaBalpha in adenomyosis. Fertil Steril 2009;92:886-9.
35. Kunz G, Beil D, Huppert P, Noe M, Kissler S, Leyendecker G. Adenomyosis in endometriosis-prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod 2005;20:2309-16.
36. Larsen SB, Lundorf E, Forman A, Dueholm M. Adenomyosis and junctional zone changes in patients with endometriosis. Eur J Obstet Gynecol Reprod Biol 2011;157:206-11.
37. Ota H, Igarashi S, Hatazawa J, Tanaka T. Is adenomyosis an immune disease? Hum Reprod Update 1998;4:360-7.
38. Ota H, Igarashi S, Sasaki M, Tanaka T. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 2001;16:561-6.
39. Wu MY, Ho HN. The role of cytokines in endometriosis. Am J Reprod Immunol 2003;49:285-96.
40. Leyendecker G, Herbertz M, Kunz G, Mall G. Endometriosis results from the dislocation of basal endometrium. Hum Reprod 2002;17:2725-36.
41. LeyendeckerG,KunzG, NoeM,HerbertzM,MallG. Endometriosis: A dysfunction and disease of the archimetra. Hum Reprod Update 1998;4:752-62.
42. Leyendecker G, Kunz G, Herbertz M, Beil D, Huppert P, Mall G, et al. Uterine peristaltic activity and the development of endometriosis. Ann N Y Acad Sci 2004;1034:338-55.
43. Kunz G, Beil D, Huppert P, Leyendecker G. Structural abnormalities of the uterine wall in women with endometriosis and infertility visualized by vaginal sonography and magnetic resonance imaging. Hum Reprod 2000; 15:76-82.
44. Leyendecker G, Kunz G,Wildt L, Beil D, Deininger H. Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endometriosis and infertility. Hum Reprod 1996;11:1542-51.
45. Goteri G, Ciavattini A, Lucarini G, Montik N, Filosa A, Stramazzotti D, et al. Expression of motility-related molecule Cdc42 in endometrial tissue in women with adenomyosis and ovarian endometriomata. Fertil Steril 2006; 86:559-65.